Callan JMB, Inc. (CJMB) AI Stock Analysis

• Market Cap: $17.45M
• Dividend Yield: N/A
• Average Volume (3M): 10.79K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.63
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 26
• Sector: Real Estate
• Sector Strength: 53
• Industry: Integrated Freight & Logistics
• EPS (TTM): N/A
• Shares Outstanding: 4,481,069
• 10 Day Avg. Volume: 12,214
• 30 Day Avg. Volume: 10,793
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: $4.00 ▲(2.56% Upside)

The overall stock score of 46 reflects significant financial challenges and bearish technical indicators. The company's declining revenues and profitability, coupled with bearish market momentum, are the most impactful factors. The absence of valuation metrics adds to the uncertainty, making it difficult to gauge the stock's attractiveness. The company needs to address operational inefficiencies and improve its financial health to enhance its stock performance.

Callan JMB, Inc. Business Overview & Revenue Model

Company Description

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.

How the Company Makes Money

CJMB generates revenue through multiple streams. Its primary revenue model is based on service contracts with businesses seeking technological solutions and consulting services. The company charges clients for software development projects, ongoing support and maintenance, and consulting fees for strategic advice. Additionally, CJMB partners with technology firms to offer integrated solutions, which can lead to revenue-sharing agreements. The company may also generate income through licensing proprietary software tools developed in-house, further diversifying its revenue sources.

Callan JMB, Inc. Financial Statement Overview

Summary

The income statement reveals significant challenges with declining revenues and profitability, although the cash flow remains positive. The balance sheet shows a stable leverage position, but weakening equity raises concerns.

Income Statement

The income statement reveals significant challenges, with a sharp decline in revenue and profitability. Gross profit margin has deteriorated, and the company has moved from a profitable position to reporting negative EBIT and net income. This indicates severe operational issues and declining market performance.

Balance Sheet

The balance sheet remains relatively stable, with a positive equity position. However, the decrease in assets and equity raises concerns. The debt-to-equity ratio remains low, suggesting manageable leverage, yet the declining equity ratio could pose future risks.

Cash Flow

Cash flows show resilience, with positive free cash flow even amidst declining revenue. Operating cash flow remains positive, suggesting effective cash management, but the significant drop from previous years highlights the need for caution in sustaining cash generation.

Breakdown	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	6.56M	13.20M	22.77M
Gross Profit	2.56M	5.65M	9.45M
EBITDA	-2.12M	2.30M	6.37M
Net Income	-2.29M	2.18M	6.22M
Balance Sheet
Total Assets	5.08M	9.71M	15.25M
Cash, Cash Equivalents and Short-Term Investments	2.10M	5.16M	6.19M
Total Debt	907.45K	400.00K	410.88K
Total Liabilities	1.91M	910.27K	1.24M
Stockholders Equity	3.17M	8.80M	14.01M
Cash Flow
Free Cash Flow	494.19K	6.51M	8.94M
Operating Cash Flow	540.35K	7.00M	9.36M
Investing Cash Flow	-46.17K	-490.02K	-422.49K
Financing Cash Flow	-3.55M	-7.54M	-4.57M

Callan JMB, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
GVH	60 Neutral	$6.11M	0.62	18.17%	―	22.89%	-46.58%
PSIG	47 Neutral	$12.18M	―	―	―	―	―
CJMB	46 Neutral	$17.45M	―	―	―	―	―